A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.
CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK – Biotech Investments
Issuer: CureVac / Key word(s): Study 01.08.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Dosing of